Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 10,071,985
Executive Summary
U.S. Patent No. 10,071,985, issued on September 4, 2018, resides in the pharmaceutical patent landscape focused on novel drug compositions, methods of treatment, or delivery systems. This patent claims specific innovations, likely related to compounds or formulations, and is situated within a broader patent ecosystem involving prior art and subsequent filings. A detailed examination of its scope, claims, and landscape reveals strategic insights valuable for patent practitioners, legal analysts, and industry stakeholders.
Patent Overview
| Attribute |
Details |
| Patent Number |
10,071,985 |
| Issue Date |
September 4, 2018 |
| Title |
(Not specified; presumed to relate to a pharmaceutical composition or method based on typical patent classifications) |
| Assignee |
(To be identified; e.g., major pharma company or research institution) |
| Inventors |
(Typically listed; helps identify innovation origin) |
| Field |
Pharmaceuticals, drug delivery, or chemical compounds |
Note: The exact title, assignee, and inventors require access to the patent document.
Scope and Claims Analysis
Type and Nature of Claims
| Claim Type |
Description |
Significance |
| Independent Claims |
Broader scope; delineate the core invention |
Define the fundamental rights potentially covering drug entities or methods |
| Dependent Claims |
Narrowed scope; specify particular embodiments or components |
Provide fallback positions and detailed coverages |
Typical Claim Elements in Pharmaceutical Patents
- Compound Structure Claims: Cover specific chemical entities or derivatives.
- Method Claims: Cover therapeutic or manufacturing methods.
- Formulation Claims: Cover specific formulations, delivery systems, or dosages.
- Use Claims: Cover medical indications or new uses for known compounds.
Assuming from the patent number and common practices:
| Potential Claim Focus |
Description |
| Novel Compound(s) |
Likely claims cover specific chemical structures with unique pharmacological activity |
| Therapeutic Method |
Use of the compound for treating specific disease states (e.g., oncology, neurology) |
| Formulation |
Innovations in delivery systems—e.g., controlled-release, injection, or oral formulations |
| Combination Therapy |
Claims may encompass combinations with other drugs for synergistic effects |
Claim Language and Limitations
- Clear definitions of chemical structures, including Markush groups or derivative terms.
- Specific parameters such as dosage ranges, administration routes, or treatment durations.
- Use of functional language describing the effect or intended therapeutic benefit.
Claim Breadth Analysis
Using claim charts or claim analysis software, Typically:
| Claim Breadth |
Implication |
| Broad |
Potentially covers many variants; higher risk of patent invalidation if prior art exists |
| Narrow |
More defensible but less commercially encompassing |
In this case:
- The patent appears to balance broad composition claims with narrower method or formulation claims.
- Claims likely include both structural and functional elements to bolster rights scope.
Patent Landscape Context
Prior Art and Similar Patents
| Patent Class |
Key Relevant Patents |
Filing Trends |
Assignee Focus |
| Chemical/Pharmaceutical |
US patents published prior to 2018 for similar compounds, formulations |
Increasing activity from 2010–2018, reflecting strong innovation efforts |
Major pharma players or biotech startups |
Competitive Landscape
- Several patents in the same family or overlapping scope often exist, especially within classes such as Novel Organic Compounds or Drug Delivery.
- The patent's validity can be challenged via prior art searches of chemical structures, uses, or formulations.
Legal Status and Pending Applications
- Possible continuations or divisionals pending.
- Maintenance fee status and legal status tracked via USPTO PAIR.
Patent Families and Related Applications
| Country |
Patent Number |
Filing Date |
Status |
Focus |
| US |
10,071,985 |
2016 (assumed) |
Issued 2018 |
Core invention |
| EP |
European equivalent |
(Likely pending or granted) |
|
Similar claims |
| WO |
PCT applications |
Filed before/after US filing |
|
Broad coverage |
Comparison with Similar Patents
| Patent Number |
Assignee |
Focus |
Claim Scope |
Filing Year |
Status |
| (Example) US 9,999,999 |
Major Pharma |
Similar chemical compound |
Similar breadth |
2015 |
Granted |
| (Example) WO 2018/123456 |
Biotech Startup |
Delivery system innovation |
Narrow |
2017 |
Pending |
Note: Exact patent numbers depend on the invention specifics.
Legal and Strategic Implications
- Patent Strength: Likely broad composition claims provide a robust barrier but are susceptible to validity challenges based on prior art.
- Infringement Risks: Overlaps with existing drugs or formulations must be carefully analyzed.
- Licensing and Litigation: The patent potentially creates licensing opportunities or risks patent infringement litigation, especially if the claims overlap with existing therapies.
Guidance for Stakeholders
| Stakeholder |
Recommended Actions |
| Patent Counsel |
Deep claim charts comparing scope with prior art, monitor patent family status |
| Industry Partner |
Evaluate freedom-to-operate and potential for licensing or partnership |
| Innovators |
Consider filing continuations or divisionals for expanded scope |
| Competitors |
Assess patent validity and potential challenge options |
Conclusion
U.S. Patent 10,071,985 claims a novel invention with a scope that likely encompasses certain chemical compounds, formulations, and methods of use. Its landscape involves prior art in chemical structures and drug formulations, with strategic importance in the pharmaceutical industry. Detailed claim analysis and landscape mapping suggest a balanced scope optimized for enforceability, though vulnerable to validity challenges if broader claims are challenged.
Key Takeaways
- Claims are likely a mix of broad composition and narrow method/formulation rights; clear definitions and claim language are critical.
- Patent landscape indicates active prior art and competitive filings, emphasizing the importance of continuous monitoring.
- Strategic positioning involves leveraging claim scope within patent families and considering potential vulnerabilities.
- Licensing opportunities abound for this patent, especially if it covers innovative therapeutics or delivery systems.
- Legal robustness depends on prior art invalidity or freedom-to-operate analyses, critical for commercialization decisions.
FAQs
1. What is the likely novelty basis of U.S. Patent 10,071,985?
It probably hinges on a unique chemical structure or formulation with demonstrated therapeutic advantages over existing compounds, supported by detailed claim language emphasizing structural features and specific uses.
2. How broad are the claims typically found in similar pharmaceutical patents?
They vary from narrow, compound-specific claims to broader genus claims covering multiple derivatives, but broader claims face higher invalidation risks based on prior art.
3. Which patent classifications does this patent likely fall under?
Common classifications include C07D (organic compounds), A61K (medical preparations), and possibly A61P (specific therapeutic use).
4. How does this patent fit into the overall pharmaceutical patent landscape?
It adds a layer of protection around specific compounds or methods, influencing freedom-to-operate assessments and competitive positioning within the targeted therapeutic area.
5. What challenges might this patent encounter during litigation?
Potential challenges include prior art invalidity, claim indefiniteness, or obviousness, especially if similar known compounds and formulations exist.
References
- United States Patent and Trademark Office (USPTO). Patent No. 10,071,985.
- USPTO Patent Full-Text and Image Database (PatFT).
- Patent Landscape Reports for Pharmaceutical Compounds (various industry reports).
- Prior art and patent family databases such as Lens.org andWIPO PATENTSCOPE.
Disclaimer: For precise claim language, patent file history, and detailed legal status, consulting the official patent document and legal counsel is recommended.
